National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.
about
Post-mastectomy radiotherapy for breast cancer patients with 1 to 3 positive lymph nodesPost-mastectomy radiotherapy for breast cancer patients with 1 to 3 positive lymph nodesSqualene epoxidase, located on chromosome 8q24.1, is upregulated in 8q+ breast cancer and indicates poor clinical outcome in stage I and II diseaseCompliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experiencePrognostic molecular markers in early breast cancerRelationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significanceGene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.Identifying patients at high risk of breast cancer recurrence: strategies to improve patient outcomesRacial/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic reviewCCNA2 is a prognostic biomarker for ER+ breast cancer and tamoxifen resistancePost-genomic clinical trials: the perspective of ACGTTraumatic Brain Injury and Neuropsychiatric ComplicationsEvaluation of Tc-99m-3PRGD2 Integrin Receptor Imaging in the Differential Diagnosis of Breast Lesions and Comparison With Mammography.Perspectives on Breast Cancer Management: Tailoring Treatment to the Individual Patient.Molecular serum portraits in patients with primary breast cancer predict the development of distant metastasesPathway-based classification of cancer subtypes.Impact of Adjuvant Endocrine Therapy on Quality of Life and Symptoms: Observational Data Over 12 Months From the Mind-Body StudyBreast cancer prognosis risk estimation using integrated gene expression and clinical dataMerging microarray data from separate breast cancer studies provides a robust prognostic test.Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy.A systems approach to clinical oncology: focus on breast cancer.Sequencing chemotherapy and radiotherapy in locoregional advanced breast cancer patients after mastectomy - a retrospective analysis.Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer.Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancerA comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all?Comparison of prognostic gene expression signatures for breast cancerDose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapy.Low expression of a few genes indicates good prognosis in estrogen receptor positive breast cancer.Spectrum of very early breast cancer in a setting without organised screening.Risk of lymphedema after mastectomy: potential benefit of applying ACOSOG Z0011 protocol to mastectomy patients.A high-throughput pharmaceutical screen identifies compounds with specific toxicity against BRCA2-deficient tumorsIdentification of breast cancer recurrence risk factors based on functional pathways in tumor and normal tissues.Search for the smallest random forest.Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer.Oncology care in rural northern new England.Derivation of cancer diagnostic and prognostic signatures from gene expression data.30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort studyRobustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival.A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients.Predictors and outcomes of surgeons' referral of older breast cancer patients to medical oncologists
P2860
Q24186275-A209D402-AAAB-4116-809C-9E363FFF6B1FQ24203952-869B2DBA-F127-4A59-9F4E-332FAE85BD3BQ24655384-744846CB-C813-4804-B397-7888328BC3BBQ24792539-2BE7F731-92FC-49E8-972A-0B6850CCFB57Q24794845-CCD1650E-C159-4E71-8E4B-A80206A2E6ADQ24813854-1185CA9F-88CC-4974-AAC4-F83A31463A92Q25257621-2591E8E3-8274-48E4-B520-C11DC92527F6Q26778675-49E2924E-7ABF-4A06-9BF7-CC9B02AEE414Q28082674-EFAEB1BE-BBB7-4577-B613-5CCC4A00D878Q28540790-5B071417-7E22-4B3A-8B91-5369EF7BA4D2Q28741720-6AF2D732-500B-4B02-BA93-FF86FCC56924Q30234431-1ADB4CB1-6CE1-42CD-BDF7-418C04AF9996Q30274889-C6139622-966B-4210-A542-574C6D8A24AEQ30319697-91AD178A-6B2A-42B0-93F3-0EAF30607ED9Q30503693-72DC4389-FA55-4FCD-90D0-DC55533B3E2CQ30527843-784E05F0-ECC1-4E33-B092-1FD889644D98Q30758966-06AA3BBD-76C6-418C-9932-842C783FAABBQ30832440-F585FE9D-D84D-4763-9BA8-A176C6991D21Q31147871-BC0F547C-678A-42E5-91DA-63A59647F427Q33224014-29452A6F-3804-4A91-8F50-9721F17390E0Q33238889-0B0612E6-A544-4BC0-B3A8-BFF5B4A8218AQ33330481-879F21AE-389C-4F8D-9BCF-4CB6F3B5876DQ33338630-B31426F7-F32D-47BC-ADDE-236C0E030492Q33345743-7DB62602-7321-476F-981E-040718E8B825Q33352632-8858A659-B792-4D7B-9A4B-8FE5E8B164A9Q33362164-AB3B3F8D-6153-4A78-A863-6B88058D30BFQ33385774-55FEBADB-0257-4C9E-9232-377902DC384FQ33484404-63E4C2AB-6BC4-436D-939F-9756D6FA6517Q33555289-F65812E7-32C5-4006-A01D-1814DA6F7DE9Q33571995-E0C83903-4970-45A5-B0D4-F3D4D3F3D9FBQ33575946-C5D546BA-4829-4064-B818-016FB3F90A29Q33591299-D0B237AD-CEAF-4751-A44D-B33C17B87809Q33654972-6DAF0E7F-AB56-4DD6-A949-692F091A7F7DQ33710557-AB937EC1-1CFB-407D-91A1-EDBB218DD78DQ33715112-474A2E8A-9A58-4439-A6B1-54C545C1F62FQ33748879-186B85C9-3643-4CA8-B1FF-573C09E64375Q33768732-F3A45D6D-091E-43D2-A527-FD8B4B45FBE6Q33831109-0AB08FA5-2B97-4B18-BF9D-B3DA7F4202ADQ33996270-99F96090-88E0-4223-875E-0796475FD19BQ34099121-0CF78543-725F-4BB7-8C84-8C2D84EF1032
P2860
National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
National Institutes of Health ...... st cancer, November 1-3, 2000.
@ast
National Institutes of Health ...... st cancer, November 1-3, 2000.
@en
National Institutes of Health ...... st cancer, November 1-3, 2000.
@nl
type
label
National Institutes of Health ...... st cancer, November 1-3, 2000.
@ast
National Institutes of Health ...... st cancer, November 1-3, 2000.
@en
National Institutes of Health ...... st cancer, November 1-3, 2000.
@nl
prefLabel
National Institutes of Health ...... st cancer, November 1-3, 2000.
@ast
National Institutes of Health ...... st cancer, November 1-3, 2000.
@en
National Institutes of Health ...... st cancer, November 1-3, 2000.
@nl
P2093
P356
P1476
National Institutes of Health ...... st cancer, November 1-3, 2000.
@en
P2093
A B Kornblith
C B Hendricks
J A Axelson
P304
P356
10.1093/JNCI/93.13.979
P407
P577
2001-07-01T00:00:00Z